LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

用生物标志物检测活跃黑色素瘤并预测存活率

By LabMedica International staff writers
Posted on 07 Aug 2018
Print article
图片:皮肤的恶性黑色素瘤(图片蒙国家癌症研究所惠赐)。
图片:皮肤的恶性黑色素瘤(图片蒙国家癌症研究所惠赐)。

黑色素瘤是最危险的一种皮肤癌,来自日晒或日光浴机的紫外线辐射常给皮肤细胞造成不可修复的DNA损伤,诱发致使皮肤细胞快速复制的突变(基因缺陷),形成恶性肿瘤,这时就会产生癌变。

 

大量黑色素瘤患者在病灶原位复发或在转移部位复发,早期检测对于新疗法的效益最大化至关重要,新疗法有免疫检查点或特定基因的抑制剂。如果发现黑色素瘤并尽早治疗,总是可治愈的,但如果做不到,癌症就会进展,并扩散到身体其它部位,这样就难以治疗,而且可能致命。

 

英国设菲尔德大学(www.sheffield.ac.uk)的临床肿瘤医师及其同事探究了血液循环中无细胞DNA (cfDNA)的新型DNA拷贝数特征谱是否可作为活跃期疾病及存活率的生物标志物。从肿瘤诊所和皮肤病诊所招募黑色素瘤患者,从库存的血浆中分离出cfDNA。科研小组使用低覆盖度全基因组测序,创建了83名黑色素瘤患者的cfDNA的拷贝数特征谱,其中44人有活跃期疾病。

 

科学家发现,拷贝数畸变分值(CNAS)能有效区分活跃期疾病(风险比= 3.1),对活跃期疾病做多变量分析时,CNAS75%分位仍是重要的区分因子。此外,针对疾病期、疾病状态(活跃还是已切除)、BRAF状态和cfDNA浓度做调整后,CNAS75%分位以上的人死亡率高于分值较低者(风险比= 3.4)。

 

该研究的论文发表于20186月的《临床化学》(Clinical Chemistry)杂志。作者总结说,他们的研究表明,cfDNA拷贝数特征谱有望成为活跃期黑色素瘤及存活率的生物标志物。有必要对拷贝数特征谱作为疾病复发的早期标志物做纵向分析。

Related Links:

设菲尔德大学>>> www.sheffield.ac.uk



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more